Cellectis (CLLS) Other Non-Current Liabilities (2014 - 2026)

Cellectis (CLLS) recorded quarterly Other Non-Current Liabilities of $1.3 million in Q1 2026, little changed quarter-over-quarter from $1.3 million in Q4 2025, and up 16.24% on a YoY basis from $1.1 million in Q1 2025.

Cellectis (CLLS) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

Cellectis' Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $1.3 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities rose 16.24% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 16.24% YoY), while the FY2025 annual figure was $1.3 million, up 19.19% from the prior year.
  • Other Non-Current Liabilities was $1.3 million for Q1 2026 at Cellectis, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.7 million in Q1 2022 to a low of $1.1 million in Q4 2024.
  • Historically, Other Non-Current Liabilities has averaged $2.1 million across 5 years, with a median of $2.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 281.79% in 2022, then plunged 49.32% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $2.4 million in 2022, then dropped by 7.95% to $2.2 million in 2023, then slumped by 49.32% to $1.1 million in 2024, then rose by 19.19% to $1.3 million in 2025, then retreated by 0.38% to $1.3 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Cellectis 17.40 Bn 17.21 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.32 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.34 Mn
Jun 30, 2025 1.30 Mn
Mar 31, 2025 1.14 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 2.43 Mn
Jun 30, 2024 2.19 Mn
Mar 31, 2024 2.24 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 2.56 Mn
Jun 30, 2023 2.64 Mn
Mar 31, 2023 2.54 Mn
Dec 31, 2022 2.39 Mn
Sep 30, 2022 2.65 Mn
Jun 30, 2022 2.85 Mn
Mar 31, 2022 3.72 Mn
Dec 31, 2021 626,000.00
Sep 30, 2021 3.85 Mn
Jun 30, 2021 3.61 Mn